Solid Lipid Nanoparticles as Drug Delivery System

Σχετικά έγγραφα
Gro wth Properties of Typical Water Bloom Algae in Reclaimed Water

Approximation Expressions for the Temperature Integral

LUO, Hong2Qun LIU, Shao2Pu Ξ LI, Nian2Bing

D-Glucosamine-derived copper catalyst for Ullmann-type C- N coupling reaction: theoretical and experimental study

Preparation of Hydroxyapatite Coatings on Enamel by Electrochemical Technique

Preparation and Characterization of Solid Dispersion of Total Flavonols from Resina Draconis

ACTA MATHEMATICAE APPLICATAE SINICA Nov., ( µ ) ( (

ER-Tree (Extended R*-Tree)

VSC STEADY2STATE MOD EL AND ITS NONL INEAR CONTROL OF VSC2HVDC SYSTEM VSC (1. , ; 2. , )

Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης Σχολή Θετικών Επιστημών Τμήμα Χημείας

Rapid Raman spectra identification and determination of levofloxacin hydrochloride injection *

Lewis Acid Catalyzed Propargylation of Arenes with O-Propargyl Trichloroacetimidate: Synthesis of 1,3-Diarylpropynes

Supporting Information

SUPPORTING INFORMATION. Polystyrene-immobilized DABCO as a highly efficient and recyclable organocatalyst for Knoevenagel condensation

Journal of Shenyang Pharmaceutical University

Studies on the Binding Mechanism of Several Antibiotics and Human Serum Albumin

Quick algorithm f or computing core attribute

( Fe 3 O 4 ) The Preparation Methods of Magnetite Nanoparticles and Their Morphology. Vol. 19 No. 6 June, 2007 PROGRESS IN CHEMISTRY )

MALMÖ UNIVERSITY HEALTH AND SOCIETY DISSERTATION 2014:3 ANTON FAGERSTRÖM EFFECTS OF SURFACTANT ADJUVANTS ON PLANT LEAF CUTICLE BARRIER PROPERTIES

17 min R A (2009) To probe into the thermal property the mechanism of the thermal decomposition and the prospective

Supporting Information

ΒΙΟΓΡΑΦΙΚΟ ΣΗΜΕΙΩΜΑ ΚΩΝΣΤΑΝΤΙΝΟΥ Ν. ΔΕΜΕΤΖΟΥ

College of Life Science, Dalian Nationalities University, Dalian , PR China.

Advance in Nanorealgar Studies

Free Radical Initiated Coupling Reaction of Alcohols and. Alkynes: not C-O but C-C Bond Formation. Context. General information 2. Typical procedure 2

Optimizing Microwave-assisted Extraction Process for Paprika Red Pigments Using Response Surface Methodology

Correction of chromatic aberration for human eyes with diffractive-refractive hybrid elements

Comparison of HPLC fingerprint between enzymatic Calculus bovis and natural Calculus bovis

- - - Zeta Zeta Zeta % Zeta - doi /cpj t 1 / h h

Basic & Clinical Medicine PLGA MUC1 MUC1 IC 50 MUC1 +

2.1

Supporting Information. Asymmetric Binary-acid Catalysis with Chiral. Phosphoric Acid and MgF 2 : Catalytic

Evolution of Novel Studies on Thermofluid Dynamics with Combustion

Antimicrobial Ability of Limonene, a Natural and Active Monoterpene

Metal-free Oxidative Coupling of Amines with Sodium Sulfinates: A Mild Access to Sulfonamides

MCF7 (PLGA) Zeta MCF7 85%,

Preparation and Application of Amorphous Alloy Catalyst

Electrolyzed-Reduced Water as Artificial Hot Spring Water

27 7 Vol. 27 No CHINESE JOURNAL OF APPLIED CHEMISTRY July CV SEM EIS DTD. MCMB / 0. 01% DTD MCMB /Li. 300 ma h /g 350 ma h /g

Vol. 5 No. 1 Feb EL ECTROCHEMISTR Y ( ) ( ) ( EHD), ( FDN) ( TEA- PTS), Tri2 tonx-100 ,FDN. EHD. EHD. RH. RH 2. Guidelli, 1.

Preparation of Novel Microcapsules by Emulsion Droplet Template Method

Novel electroluminescent donor-acceptors based on dibenzo[a,c]phenazine as

J. of Math. (PRC) 6 n (nt ) + n V = 0, (1.1) n t + div. div(n T ) = n τ (T L(x) T ), (1.2) n)xx (nt ) x + nv x = J 0, (1.4) n. 6 n

Apr Vol.26 No.2. Pure and Applied Mathematics O157.5 A (2010) (d(u)d(v)) α, 1, (1969-),,.

J. of Math. (PRC) Banach, , X = N(T ) R(T + ), Y = R(T ) N(T + ). Vol. 37 ( 2017 ) No. 5

Polymer-Based Composites with High Dielectric Constant and Low Dielectric Loss

ACTA CHIMICA SINICA. 5 Zn2Al HTlc PZNC. Studies of the Point of Zero Net Charge and Isoelectric Point of Zn2Al Hydrotalcite2like Compounds

FENXI HUAXUE Chinese Journal of Analytical Chemistry. Savitzky-Golay. n = SG SG. Savitzky-Golay mmol /L 5700.

A System Dynamics Model on Multiple2Echelon Control

1-4 certified reference material CRM. DSC HPLC ± 0. 4 % k = 2 P = GBW

CuS * CuS. THz. CuS. THz-TDS. CuS. 1 THz = 33 cm - 1. THz. PACS Ci Bd. CuS. THz. THz. CuS. CuS. THz. http / / wulixb. iphy. ac.

Supplementary Information. Living Ring-Opening Polymerization of Lactones by N-Heterocyclic Olefin/Al(C 6 F 5 ) 3

Table of contents. 1. Introduction... 4

Supporting information. An unusual bifunctional Tb-MOF for highly sensing of Ba 2+ ions and remarkable selectivities of CO 2 /N 2 and CO 2 /CH 4

Development of a Tiltmeter with a XY Magnetic Detector (Part +)

- A. A Biphenol A BPA BPA BPA LLE 5 SPE Electrospinning Kang. Packed-fiber solid-phase extraction PFSPE 1 ml

Synthesis Characterization and Application of Phosphorus-Containing Derivatives of Chitosan

Studies on Synthesis and Biological Activities of 2( 1 H21,2,42 Triazol212yl)2 2Arylthioethyl Substituted Phenyl Ketones

Quantum dot sensitized solar cells with efficiency over 12% based on tetraethyl orthosilicate additive in polysulfide electrolyte

HIV HIV HIV HIV AIDS 3 :.1 /-,**1 +332

PNS mg kg - 1. Rb 1

Comparison of carbon-sulfur and carbon-amine bond in therapeutic drug: -S-aromatic heterocyclic podophyllum derivatives display antitumor activity

ΕΞΕΛΙΞΕΙΣ ΣΤΑ ΣΥΣΤΗΜΑΤΑ ΕΛΕΓΧΟΜΕΝΗΣ ΧΟΡΗΓΗΣΗΣ ΦΑΡΜΑΚΩΝ

The Study and Application of Film Coated Pellets in the Prep aratio n of Pharmaceutic s

Journal of Fuzhou University Natural Science Edition. The preparation and visible - light photocatalysis of Ag 3 PO 4 /TiO x N y

Antibacterial property of fabric treated with a fiber-reactive chitosan derivative

Motion analysis and simulation of a stratospheric airship

Stress Relaxation Test and Constitutive Equation of Saturated Soft Soil

The Exploitation and Utilization of Magnesium Resources in Salt Lakes

Study on the Solubility of Kiwi Fruit Seed Oil in Supercritical Carbon Dioxide

LUNGOO R. Control Engineering for Development of a Mechanical Ventilator for ICU Use Spontaneous Breathing Lung Simulator LUNGOO

1 (forward modeling) 2 (data-driven modeling) e- Quest EnergyPlus DeST 1.1. {X t } ARMA. S.Sp. Pappas [4]

Supporting Information. Enhanced energy storage density and high efficiency of lead-free

Study on Purification Technology and Antioxidant Activity of Total Flavonoid from Eriobotryae Folium

,,, (, ) , ;,,, ; -

phase: synthesis of biaryls, terphenyls and polyaryls

GF GF 3 1,2) KP PP KP Photo 1 GF PP GF PP 3) KP ULultra-light 2.KP 2.1KP KP Fig. 1 PET GF PP 4) 2.2KP KP GF 2 3 KP Olefin film Stampable sheet

P Ë ³μ,.. μ μ³μ²μ,.. ŠμÎ μ,.. μ μ,.. Š μ. ˆ œ ˆ Š Œˆ ŠˆŒ ƒ Œ Ÿ ˆŸ Š ˆ ˆ -ˆ ˆŠ

BGP TRACP-5b BGP TRACP-5b P 0.05

Vol. 31,No JOURNAL OF CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY Feb

IL - 13 /IL - 18 ELISA PCR RT - PCR. IL - 13 IL - 18 mrna. 13 IL - 18 mrna IL - 13 /IL Th1 /Th2

Supplementary material

Development of a Seismic Data Analysis System for a Short-term Training for Researchers from Developing Countries

Research on explaining porosity in carbonate reservoir by capture cross section method

Study on the Strengthen Method of Masonry Structure by Steel Truss for Collapse Prevention

The Research on Sampling Estimation of Seasonal Index Based on Stratified Random Sampling

Q L -BFGS. Method of Q through full waveform inversion based on L -BFGS algorithm. SUN Hui-qiu HAN Li-guo XU Yang-yang GAO Han ZHOU Yan ZHANG Pan

Laboratory Studies on the Irradiation of Solid Ethane Analog Ices and Implications to Titan s Chemistry

PROGRESS IN CHEMISTRY. ,ZnO. Yang Sen Ni Yonghong 3 3. (No )

1 h, , CaCl 2. pelamis) 58.1%, (Headspace solid -phase microextraction and gas chromatography -mass spectrometry,hs -SPME - Vol. 15 No.

16 1 Vol. 16 No ELECTROCHEMISTRY Feb MnO 6 Bir-Co5% Bir-Co10% Bir-Co15% Bir-Co20%. 3 3 Li mol L - 1 MgCl 2.

No. 7 Modular Machine Tool & Automatic Manufacturing Technique. Jul TH166 TG659 A

Vol. 37 ( 2017 ) No. 3. J. of Math. (PRC) : A : (2017) k=1. ,, f. f + u = f φ, x 1. x n : ( ).

9-amino-(9-deoxy)cinchona alkaloids-derived novel chiral phase-transfer catalysts

ΜΕΛΕΤΗ ΤΗΣ ΠΛΑΣΤΙΚΟΤΗΤΑΣ ΑΡΓΙΛΟΥΧΩΝ ΜΙΓΜΑΤΩΝ ΜΕ ΠΡΟΣΘΗΚΗ ΣΙΔΗΡΑΛΟΥΜΙΝΑΣ ΑΠΟ ΤΗ ΔΙΕΡΓΑΣΙΑ BAYER

MnZn. MnZn Ferrites with Low Loss and High Flux Density for Power Supply Transformer. Abstract:

Research Progress in Lattice Matching and Electrostatic Compatibility in Growth of Biominerals Induced by Monolayers

PACS: Ox, Cw, a, TP

Table S1. Summary of data collections and structure refinements for crystals 1Rb-1h, 1Rb-2h, and 1Rb-4h.

Schedulability Analysis Algorithm for Timing Constraint Workflow Models

Transcript:

19 1 2007 1 PROGRESS IN CHEMISTRY Vol. 19 No. 1 Jan., 2007 3 ( 250100) : O64811 ; R944 : A : 10052281X(2007) 0120087206 Solid Lipid Nanoparticles as Drug Delivery System Li Xinwei Sun Lixin Lin Xiaohong Zheng Liqiang 3 ( Key Laboratory of Colloid and Interface Chemistry of Ministry of Education, Shandong University, Jinan 250100, China) Abstract Solid lipid nanoparticle is a new drug delivery system of nano2range. This paper reviews research development of solid lipid nanoparticle as drug carrier, including its components, preparation and surfacial modification, as well as its physico2chemical characteristics, drug incorporation and drug release. Key words solid lipid nanoparticles ; drug delivery system ; drug encapsulation OΠW [1 ] OΠW ;, ; ( solid lipid nanoparticles, SLN) 20 90,, 50 1 000nm,,SLN, : 2006 2, : 2006 4 3 e2mail :lqzheng @sdu. edu. cn

88 19 ; 10, ] SLN 1 SL N 111 SLN SLN 3 [11 M ller Gasco, ] M hlen [12 ] [2 Westesen ] SLN SLN SLN Heiata [13 ] [3 ] 1995 (trilaurin, TL) [4,5 SLN ] (azidothymidine, AZT) SLN (AZT2Palmitate,AZT2P) SLN,, DPPC ( dipalmitoylphosphatidy2 lcholine), SLN,,SLN DPPC :DMPG(dimyristoylphosphatidylglycerol) SLN (203 31) nm SLN (294 32) nm 113 SLN SLN SLN SLN DNA SLN ( 1) SLN (nanostructured lipid carrier, NLC) ( lipid drug conjugate nanoparticles, LDC) [6 ] NLC 1 SLN SLN, Fig. 1 Model of SLN NLC, Gasco [14 ] A SLN LDC A 610 % 250nm 0125 2 Mader [7 ] LDC 112 SLN SLN, [ ] [ (dynasan 112) (dynasan 116) ( dynasan 114) [14 ] ( imwitor 900 ) 2 SLN ] [ Fig. 2 Transmission electron micrograph of SLN (dynasan118) ] [ ] [14 ] [7 Mehnert Mgder,SLN

1 89 SLN 10nm (250 35) nm 01334 Gasco [15 ] SLN 213 XRD(X2ray diffraction) SLN SLN SLN 2 SL N 211 60 ; ;400W 10min 60, Ahlin [16] SLN 1h,,4 [20 Zeta ] Brij78 SLN : 2 000rpm 8min ; 5 000rpm 10min Dynasan RES : 25 000rpm 10min 5ml 25ml 5 000rpm 10min 212 1 000rpm (75 2) 4h 10ml ;, (0 2) 1 000rpm 30ml 2h, SLN 50 100 m, 5 10 214 2 SLN [3 ] SLN ; [17 ] SLN Hodoshima [21] Souto [9 ] (PEGlipid) (phosphatidylcholine, Ultra2Turrax T25 142O2hexadecanoyl23 2N2salicylidene2 1min (8 000rpm) 500bar 3 ;, [19 ] : Brij78 25ml 6 SLN : 90 5 % PC) DPPC 42O2 2 ( ) ; (THP2ADM) SLN THP2ADM THP2ADM; PEG2lipid,PC DPPC SLN 200 300nm 3 5 5 7 2 SLN (4 1) 60 % Yang [18 ] ; 0124 mol L - 1 10 % 5 30 50nm SLN ( 20,SLN ) 215

90 19 SLN SLN SLN OΠW (2 3 ) : Zeta [25 SLN ] 411 Zeta SLN (dynamic light scattering,dls) (photo correlation spectroscopy, PCS) ( 1 25 1 50) Ugazio [22 ] A2SLN 3 SL N [25 ],, Zeta, Zeta SLN 412 SLN ( PEG) SLN SLN,,SLN [26 ] [23 ] SLN DSC) X ( small angle X2ray scattering, Garcia2Fuentes [24 ] 2 ( PEG2 stearate) SLN (R) PEG R2PEG SLN,R PEG,DSC 4 SL N, ( differential scanning calorimetry, SAXS) DSC X X SLN X

1 91 [31 SLN ] Raman SLN SLN, SLN Lippacher [27 ],SLN [32],,SLN [33 SLN, ] SLN (nuclear magnetic resonance,nmr) (electron spin resonance,esr) SLN H 1 NMR 514 SLN, [28 ] ESR ESR 6 SL N ESR SLN,SLN 3 [29 ] [34 3 ] : (1) ; (2) 2 5 SL N 511 513 E SLN,, ; (3) 2, SLN SLN 3 SLN : ( ) ; 2 [30 ], ( ) ; 2, ( ) [34 ] 512 Fig. 3 Models of incorporation of active compounds into SLN : SLN homogeneous matrix (left), compound2free core with compound SLN enriched in outer shell (middle), drug2enriched core with lipid shell (right) [34 ],, SLN ; (CA) SLN, CA [35,36 ],CA AUC (area under the concentration2time) SLN MTR(mean residence time) AUC SLN

92 19 SLN [ 6 ] M, [ 8 ] M, OΠW [12] Zur M, SLN SLN [37 ] DNA [19] SLN SLN Schubert [38] (BSA) SLN 215 % 10 % 61 674nm,Zeta - 2314mV - 019mV 7 SLN, SLN [ 1 ] M ller R H, Hildebrand G E ( eds. ). Pharmazeutische Technologie : Moderne Arzneiformen. Stuttgart, Germany : Wissenschaftliche Verlag GmbH, 1998 [ 2 ] Siekmann B, Westesen K. Pharm. Pharmacol. Lett., 1992, 123 126 [ 3 ] M ller R H, Mehnert W, Lucks J S. Eur. J. Pharm. Biopharm., 1995, 41 : 62 69 [ 4 ] M ller R H, Mader K, Gohla S. Eur. J. Pharm. Biopharm., 2000, 50 : 161 177 [ 5 ] Mehnert W, Mgder K. Adv. Drug Deliv. Rev., 2001, 47 : 165 196 ller R H, Keck C M. J. Biotech., 2004, 113 : 151 170 [ 7 ] Jores K, Mehnert W, Mgder K, et al. J. Control. Release, 2004, 95 : 217 227 ller R H, Radtke M, Wissing S A. Int. J. Pharm., 2002, 242 : 121 128 [ 9 ] Souto E B, Wissing S A, M ller R H, et al. Inter. J. Pharm., 2004, 278 : 71 77 [10] Lukowski G, Kasbohm J, Wulff H, et al. Inter. J. Pharm., 2000, 196 : 201 205 [11] Plipps L W. College of Estate Management, 1985, 44 78 hlen A. PhD Thesis, Free University of Berlin, 1996 [13] Heiata H, Rashad T, Richard R S, et al. Int. J. Pharm., 1997, 146(1) : 123 131 [14] Ugazio E, Cavalli R, Gasco M R. Inter. J. Pharm., 2002, 241 : 341 344 [15] Souto E B, Wissing S A, M ller R H, et al. Eur. J. Pharm. Biopharm., 2004, 58 : 83 90 [16] Ahlin P, Kristl J, Smid2Kobar J. Acta Pharm., 1998, 48 : 259 267 [17] M ller R H, Radtke M, Wissing S A. Adv. Drug Delivery Rev., 2002, 54(1) : 131 155 [18] Yang S C, Zhu J B. Drug Dev. Ind. Pharm., 2002, 28 (3) : 265 274 ( Yin X Y), (Hu F Q), ( Yun H). ( China Medicamentous Industry), 2002, 33 (11) : 543 545 [20] (Chen D B), (Wang J), (Zhang Q). ( ) (J. Peking Univ. Health Sci. ), 2001, 33(3) : 233 237 [21] Hodoshima N, Udagawa C, Ando H, et al. Int. J Pharm., 1997, 146(1) : 81 92 [22] Ugazio E, Cavalli R, Gasco M R. Int. J. Pharm., 2002, 241 (2) : 341 344 [23] (Wang J), (Zhang Q). Π (Foreign Medical Sci. Sec. Pharmarcy), 1999, 6 : 25 31 [24] Garcia2Fuentes M, Alonso M J, Torres D J. Colloid Interf. Sci., 2005, 285 : 590 598 [25] Mehnert W, Mader K. Adv. Drug Delivery Rev., 2001, 47 : 165 196 [26] Sato K. Crystallization and Polymorphism of Fats and Fatty Acids. New York : Marcel Dekker Inc., 1988. 227 266 [27] Lippacher A, M ller R H, Mader K. Int. J. Pharm., 2000, 196 : 227 230 [28] Jenning V. PhD Thesis, Free University of Berlin, 1999 [29] Liedtke S, Zimmermann E, Mader K, et al. Proc. Intern. Symp. Control. Rel. Bioact. Mater., 1999, 26 : 599 600 [30] Zara G P, Cavalli R, Fundaro A, et al. Pharm. Res., 1999, 40 (3) : 281 286 [31] Yang S, Zhu J, Lu Y, et al. Pharm. Res., 1999, 16 (5) : 751 757 [32] Dingler A, Blum R P, Niehus H, et al. J. Microencapsulation, 1999, 16(6) : 751 767 [33] Wissing S A, Muller R H. Pharmazie, 2001, 56(10) : 783 786 [34] M ller R H, Radtke M, Wissing S A. Adv. Drug. Delivery Rev., 2002, 54 : 131 135 [35] Ahlin P, Kristl J, Sentjurc M, et al. Int. J. Pharm., 2000, 196 (2) : 241 244 [36] Jenning V, Gohla S H. J. Microencapsul., 2001, 18(2) : 149 158 [37] Zur M hlen A, Schwarz C, Mehnert W. Eur. J. Pharm. Biopharm., 1998, 45 : 149 155 [38] Schubert M A, M ller2goymann C C. Eur. J. Pharm. Biopharm., 2005, 61 : 77 86